mother
milk
deliv
natur
breastfeed
sole
sourc
infant
nutrit
mammalian
speci
million
year
sinc
human
be
learn
domest
cattl
year
ago
nonhuman
mammalian
milk
also
use
supplement
replac
matern
milk
human
infant
develop
widespread
use
commerci
prepar
infant
formula
product
phenomena
centuri
notabl
past
decad
addit
inform
acquir
last
sever
year
reinforc
exist
concept
role
breastfeed
protect
infant
infect
provid
ideal
sourc
infant
nutrit
modul
infecti
immun
respons
suppress
evolut
neoplasm
autoimmun
diseas
later
life
past
decad
immun
respons
intestin
respiratori
mucos
surfac
local
infect
intens
studi
investig
led
develop
concept
immun
mucos
surfac
gastrointestin
respiratori
genitourinari
tract
identif
mucosaassoci
lymphoid
tissu
malt
local
mechan
defens
distinct
intern
system
immun
system
chapter
review
exist
inform
major
aspect
physiolog
nutrit
immunolog
antiinfect
compon
product
lactat
also
discuss
recent
evid
contribut
human
milk
develop
immunolog
integr
infant
influenc
outcom
infect
hostantigen
interact
neonat
chapter
dedic
lar
hansen
md
phd
discover
siga
human
milk
father
modem
mother
milk
feed
practic
remark
human
rudimentari
mammari
tissu
undergo
sever
development
chang
morphogenesi
lactogenesi
human
embryo
breast
tissu
appear
tini
mammari
band
chest
embryon
stage
mammari
band
develop
mammari
line
along
eventu
develop
true
mammari
anlag
stage
primit
epitheli
nodul
develop
stage
primit
mammari
bud
appear
initi
phase
develop
take
place
gender
tabl
develop
male
howev
appear
limit
androgen
maleassoci
castrat
male
rat
embryo
earli
gestat
lead
femal
breast
develop
wherea
ovariectomi
femal
alter
cours
develop
mammari
anlag
toward
end
pregnanc
initi
phase
fetal
mammari
differenti
seem
occur
influenc
placent
transplacent
acquir
matern
hormon
transient
develop
excretori
lactifer
ductular
system
growth
differenti
secretori
activ
transient
regress
soon
birth
thelarch
later
menarch
true
mammari
growth
develop
begin
associ
rapidli
increas
level
estrogen
progesteron
growth
hormon
insulin
adrenocorticosteroid
prlactin
estrogen
appear
import
growth
develop
ductular
system
progestin
lobuloalveolar
develop
see
tabl
final
differenti
breast
associ
growth
prolifer
acinar
lobe
alveoli
continu
influenc
level
estrogen
progesteron
peptid
hormon
prolactin
insulin
placent
chorion
somatomammotropin
appear
far
import
subsequ
induct
mainten
lactat
see
tabl
appear
prolactin
secret
pituitari
gland
neural
control
increas
innerv
breast
observ
throughout
pregnanc
regul
estrogen
intens
neural
input
virgin
parturi
current
pregnant
mammal
shown
result
lactat
exampl
lactat
goat
induc
milk
maneuv
adopt
breastfeed
also
well
document
primit
human
societi
sudden
perman
cessat
suckl
result
termin
milk
secret
involut
breast
prepregn
state
concentr
prolactin
declin
estrogen
progesteron
also
may
amplifi
direct
effect
prolactin
may
induc
addit
receptor
peptid
hormon
appropri
target
tissu
breast
breast
tissu
respons
hormon
even
rudimentari
structur
illustr
secret
witch
milk
male
femal
newborn
respons
exposur
matern
secret
placent
lactogen
estrogen
progeteron
secret
earli
milk
ceas
exposur
matern
hormon
wane
sexual
differenti
mark
puberti
next
major
stage
mammari
develop
point
earlier
androgen
inhibit
develop
mammari
tissu
male
wherea
develop
mammari
tissu
femal
depend
estrogen
progesteron
pituitari
postpubert
mammari
gland
undergo
cyclic
chang
respons
releas
hormon
take
place
menstrual
cycl
last
stage
develop
occur
menopaus
declin
estrogen
secret
result
atrophi
mammari
tissu
menstrual
cycl
mammari
gland
respond
sequenti
releas
estrogen
progesteron
hyperplasia
ductal
system
continu
secretori
phase
declin
onset
menstruat
concentr
prolactin
modestli
increas
follicular
stage
menstrual
cycl
remain
constant
secretori
phaseg
prolactin
secret
appear
held
readi
induct
mainten
lactat
initi
mainten
lactat
pregnanc
mark
profound
hormon
chang
reflect
major
secretori
contribut
placenta
hypothalamu
pituitari
gland
contribut
number
endocrin
gland
eg
pancrea
thyroid
parathyroid
increas
estrogen
progesteron
level
pregnanc
stimul
secret
prolactin
pituitari
wherea
placent
lactogen
appear
inhibit
releas
prolactininhibit
factor
hypothalamu
prolactin
lactogen
estrogen
progesteron
aid
prepar
mammari
gland
lactat
initi
gestat
increas
growth
ductul
alveolobular
tissu
occur
respons
estrogen
progesteron
begin
second
trimest
secretori
materi
begin
appear
lumin
cell
middl
second
trimest
mammari
develop
proceed
suffici
permit
lactat
occur
parturit
take
place
infant
deliv
major
regulatori
factor
placenta
lost
new
regulatori
factor
includ
maternalinf
interact
neuroendocrin
regul
gain
control
lactat
loss
placent
hormon
secret
result
endocrin
hypothalam
stimul
prolactin
releas
anterior
pituitari
gland
well
neural
stimul
oxytocin
posterior
pituitari
stimul
nippl
suckl
activ
neural
pathway
result
releas
prolactin
oxytocin
prolactin
respons
stimul
milk
product
wherea
oxytocin
stimul
milk
eject
combin
known
letdown
reflex
oxytocin
also
stimul
uterin
contract
mother
may
feel
breastfeed
respons
help
restor
uteru
prepregn
tone
milk
product
eject
thu
depend
complex
interact
stimul
infant
suckl
neural
reflex
hypothalamu
stimul
releas
hormon
anterior
posterior
pituitari
respons
mammari
gland
hormon
complet
cycl
mik
secret
milk
produc
result
synthet
mechan
within
mammari
gland
well
transport
compon
blood
milkspecif
protein
synthes
mammari
secretori
cell
packag
secretori
vesicl
exocytos
alveolar
lumen
lactos
secret
milk
similar
manner
wherea
mani
monoval
ion
sodium
potassium
chlorid
depend
activ
transport
system
base
sodiumpotassium
adenosin
triphosphatas
na
katpas
situat
mammari
epithelium
may
behav
mammari
barrier
interstiti
fluid
deriv
blood
milk
lack
space
cell
may
leak
permit
direct
diffus
compon
milk
barrier
result
format
differ
pool
compart
milk
compon
within
mammari
gland
respons
maintain
gradient
compon
blood
milk
lipid
droplet
observ
within
secretori
cell
mammari
gland
surround
milk
fat
globul
membran
fat
droplet
appear
fuse
apic
membran
secretori
cell
either
exocytos
pinch
f
f
whole
cell
also
found
milk
includ
leukocyt
macrophag
lymphocyt
broken
shed
mammari
epitheli
cell
mechan
cell
enter
milk
complex
includ
among
other
specif
cellular
receptormedi
home
antigen
sensit
lymphocyt
structur
mammari
gland
compartment
milk
gross
composit
milk
consist
cytoplasm
encas
cellular
membran
milk
fat
globul
membran
fat
compart
made
fat
droplet
solubl
compart
contain
watersolubl
constitu
caseinmicel
compart
contain
acidprecipit
protein
calcium
lactos
cellular
compart
rel
amount
compon
chang
cours
lactat
gener
less
fat
protein
earli
lactat
late
lactat
thu
infant
consum
dynam
complex
solut
physic
properti
permit
uniqu
separ
differ
function
constitu
one
anoth
presum
form
best
support
growth
develop
lactat
perform
success
lactat
perform
depend
continu
effect
contribut
neural
endocrin
maternalinf
interact
initi
time
deliveri
part
complex
behavior
liabl
inhibit
motherchild
interact
earli
attach
infant
breast
mandatori
begin
stimul
neural
pathway
essenti
maintain
prolactin
oxytocin
releas
healthi
newborn
infant
place
mother
breast
locat
nippl
begin
suck
spontan
within
first
hour
birth
rapid
attach
mother
may
reflect
olfactori
stimuli
breast
receiv
infant
birth
frequent
feed
necessari
mother
maintain
appropri
level
milk
product
infant
proper
growth
develop
program
support
lactat
perform
must
emphas
proper
maternalinf
bond
relax
mother
support
mother
technic
assist
initi
breastfeed
properli
cope
problem
reduct
environment
hindranc
hindranc
may
includ
lack
roomingin
hospit
use
extra
formula
feed
lack
conveni
day
care
work
mother
lactat
ceas
suckl
stop
therefor
behavior
reduc
amount
suckl
infant
initi
wean
end
lactat
introduct
water
bottl
bottl
formula
day
may
begin
wean
process
regardless
time
parturit
damag
process
motherinf
dyad
first
establish
lactat
colostrum
milk
contain
rich
divers
nutrient
includ
electrolyt
vitamin
miner
trace
metal
nitrogen
product
enzym
immunolog
specif
cellular
solubl
product
distribut
rel
content
variou
nutrit
substanc
found
human
milk
present
tabl
chemic
composit
often
exhibit
consider
variat
among
lactat
women
woman
differ
time
tabl
distribut
secretori
product
human
colostrum
milk
chemic
compon
especi
nitrogen
calcium
sodium
decreas
significantli
durat
lactat
increas
sever
compon
howev
found
chang
concentr
function
water
content
total
daili
output
appear
remark
constant
least
first
week
milk
product
progress
three
distinct
phase
character
secret
colostrum
transit
earli
milk
matur
milk
colostrum
compris
lactat
product
detect
first
day
lactat
consist
yellowish
thick
fluid
mean
energi
valu
greater
kilocalori
kcal
dl
contain
high
concentr
immunoglobulin
protein
fat
fatsolubl
vitamin
ash
transit
milk
usual
observ
day
lactat
matur
milk
found
thereaft
concentr
mani
nutrit
compon
declin
milk
product
progress
synthesi
matur
milk
content
fatsolubl
vitamin
protein
decreas
water
content
milk
increas
convers
level
lactos
fat
watersolubl
vitamin
total
calor
content
shown
increas
lactat
matur
result
sever
manufactur
error
nutrient
composit
infant
formula
l
e
g
il
e
result
paradox
situat
human
milk
may
alway
meet
recommend
standard
nutrient
wherea
infant
formula
may
exceed
recommend
human
milk
nutrient
composit
vari
time
lactat
colostrum
versu
earli
milk
versu
matur
milk
extent
matern
nutrit
statu
appropri
amount
nutrient
must
consid
within
constraint
mineralsth
miner
content
human
milk
low
rel
infant
formula
low
compar
cow
milk
formula
prepar
although
human
milk
suffici
support
growth
develop
also
repres
fairli
low
solut
load
develop
kidney
level
major
miner
tend
declin
lactat
except
magnesium
consider
variabl
among
women
sodium
potassium
chlorid
calcium
zinc
phosphoru
appear
bioavail
human
milk
infant
formula
reflect
lower
concentr
human
milk
iron
readili
bioavail
infant
human
milk
may
supplement
later
preterm
infant
fed
human
milk
may
need
supplement
calcium
vitamin
human
milk
contain
suffici
vitamin
maintain
infant
growth
develop
caveat
watersolubl
vitamin
particularli
depend
matern
intak
preterm
infant
may
requir
supplement
vitamin
e
k
fed
human
low
content
vitamin
human
milk
relat
develop
ricket
breastf
infant
discuss
vitamin
defici
may
particular
problem
breastf
infant
expos
least
minut
sunshin
per
week
carbohydr
energi
lactos
primari
sugar
found
human
milk
usual
carbohydr
chosen
prepar
commerci
formula
lactos
suppli
approxim
half
energi
total
kcaldl
taken
infant
human
milk
lactos
disaccharid
glucos
galactos
also
may
import
neonat
carrier
galactos
may
readili
incorpor
gangliosid
central
nervou
system
galactos
deriv
glucos
also
glycogen
may
synthes
effici
galactos
glucos
neonat
rel
low
activ
glucokinas
earli
deelop
human
milk
also
contain
sugar
includ
glucos
galactos
differ
oligosacharid
oligosaccharid
may
protect
function
infant
especi
respect
abil
bind
gastrointestin
lipid
fat
provid
almost
half
calori
human
milk
primarili
form
triacylglycerol
triglyerid
lipid
suppli
form
fat
globul
enclos
plasma
membran
deriv
mammari
epitheli
essenti
fatti
acid
linol
acid
suppli
calori
deriv
lipid
fraction
triacylglycerol
serv
precursor
prostaglandin
steroid
phospholipid
carrier
fatsolubl
vitamin
lipid
profil
human
milk
differ
dramat
commerci
formula
despit
consider
adapt
formula
human
milk
lipid
absorb
effici
infant
cholesterol
import
lipid
constitu
human
milk
mgdl
usual
found
trace
amount
commerci
formula
suggest
cholesterol
may
essenti
nutrient
lack
cholesterol
earli
develop
may
result
turn
cholesterolsynthet
mechan
difficult
turn
later
life
influenc
induct
studi
suggest
breastfeed
neonat
associ
lower
adult
serum
cholesterol
level
reduc
death
ischem
heart
diseas
recent
interest
increas
role
longchain
polyunsatur
fatti
acid
lcpufa
may
play
human
milk
especi
docosahexaeno
acid
dha
arachidon
acid
aa
lcpufa
found
unsuppl
infant
formula
present
human
milk
structur
compon
brain
retin
membran
thu
may
import
cognit
visual
develop
addit
may
role
prevent
tp
numer
studi
found
infant
fed
formula
without
dha
aa
reduc
red
blood
cell
amount
fatti
howev
find
visual
cognit
function
studi
term
infant
n
c
ni
e
n
studi
complic
find
slower
growth
preterm
infant
fed
lcpufasuppl
inconsist
find
supplement
formulaf
babi
may
reflect
difficulti
determin
optim
amount
dha
aa
precursor
linol
linolen
acid
supplement
formula
thu
lipid
appear
best
deliv
human
milk
protein
nonprotein
nitrogen
exact
protein
content
matur
human
milk
variabl
fall
close
logdl
contrast
infant
formula
usual
contain
gdl
milk
mother
deliv
preterm
infant
may
slightli
protein
nutrit
avail
protein
may
even
less
gdla
low
gdla
result
proport
protein
util
nonnutrit
purpos
addit
human
milk
contain
consider
greater
percentag
nonprotein
nitrogen
total
nitrogen
compar
formula
total
nitrgen
human
milk
protein
primarili
whey
predomin
acidsolubl
protein
wherea
formula
prepar
bovin
milk
classic
reflect
casein
protein
composit
speci
wheytocasein
protein
ratio
human
may
chang
lactat
whey
compon
rang
earli
milk
matur
milk
late
rnilk
l
formula
preterm
infant
reconstitut
bovin
milk
provid
whey
casein
protein
major
formula
term
infant
unit
state
bovin
whey
proteinpredomin
prepar
attempt
make
closer
human
milk
composit
differ
protein
qualiti
reflect
differ
plasma
urin
amino
acid
respons
infant
fed
human
milk
formula
casein
protein
predomin
whey
protein
p
r
e
dm
n
n
gener
howev
term
infant
respond
dramat
differ
seen
preterm
infant
fed
formula
differ
protein
qa
l
nonprotein
nitrogen
compon
human
milk
contain
varieti
compound
may
import
develop
neonat
polyamin
nucleotid
creatinin
urea
free
amino
acid
carnitin
ar
n
e
signific
presenc
compon
alway
clear
fed
case
infant
formula
contain
littl
soy
formula
contain
littl
carnitin
appar
defici
may
influenc
develop
infant
occur
taurin
import
bile
salt
conjug
well
support
appropri
develop
brain
retina
wherea
carnitin
appear
import
appropri
fatti
acid
nucleotid
particular
appear
bridg
gap
nutrit
immunolog
role
human
milk
compon
human
milk
contain
major
compound
form
polymer
nucleotid
nucleic
wherea
formula
contain
nucleotid
supplement
monomer
form
tabl
nucleotid
appear
enhanc
intestin
develop
promot
iron
absorpt
modifi
lipid
metabol
nutrit
hand
compound
perform
immunolog
function
promot
killer
cell
cytotox
product
stimul
mononuclear
cell
infant
either
breastf
fed
nucleotidesuppl
nucleotid
supplement
also
report
reduc
number
episod
infant
diarrhea
group
lowersocioeconomicstatu
infant
chile
manner
analog
protect
afford
human
milk
report
nucleotidesuppl
formula
promot
immun
respons
infant
haemophilu
influenza
type
b
polysaccharid
immun
month
age
similar
respons
observ
diphtheria
infant
fed
human
milk
month
demonstr
similar
respons
also
exhibit
enhanc
titer
respons
oral
polio
vaccin
latter
respons
observ
nucleotidesuppl
formulaf
thu
nucleotid
emerg
nutrit
immunolog
compon
human
milk
nutrit
protein
note
nutrit
protein
human
milk
classifi
either
whey
acidsolubl
casein
acidprecipit
within
two
class
protein
sever
specif
protein
respons
support
nutrit
need
infant
human
casein
made
primarili
pand
kcasein
although
actual
distribut
two
protein
contrast
bovin
milk
contain
asland
casein
neither
found
human
milk
addit
pand
two
human
milk
casein
protein
appear
account
approxim
protein
found
human
milk
contrast
earlier
calcul
amount
commonli
use
prepar
reconstitut
socal
human
formula
bovin
milk
normal
contain
casein
protein
whey
protein
fraction
contain
propos
function
protein
human
milk
immunoglobulin
lysozym
lactoferrin
enzym
cytokin
peptid
hormon
addit
major
nutrit
protein
alactalbumin
whey
protein
make
approxim
human
milk
protein
contrast
bovin
milk
wherea
alactalbumin
major
whey
protein
human
milk
plactoglobulin
major
whey
protein
bovin
milk
found
human
milk
consist
fraction
human
milk
whey
protein
made
serum
albumin
sourc
remain
unclear
evid
indic
may
synthes
mammari
serum
albumin
howev
probabl
synthes
outsid
mammari
gland
thu
milk
protein
character
site
synthesi
well
speci
specif
therefor
protein
alactalbumin
plactoglobulin
speci
organ
specif
wherea
protein
serum
albumin
speci
specif
organ
pecif
net
result
differ
protein
util
nutrit
neonat
differ
amount
amino
acid
ingest
neonat
depend
sourc
milk
even
reconstitut
whey
casein
class
protein
one
speci
ratio
similar
anoth
speci
result
ident
amino
acid
intak
differ
reflect
plasma
amino
acid
profil
infant
fed
commerci
milk
versu
human
milk
regardless
ratio
bioactiv
protein
peptid
wherea
major
proport
human
milk
protein
compos
nutrit
protein
describ
signific
number
remain
protein
subserv
varieti
function
either
addit
nutrit
support
neonat
protein
includ
carrier
protein
enzym
hormon
growth
factor
immunoglobulin
cytokin
latter
two
discuss
later
resist
infect
whether
protein
still
function
ingest
neonat
alway
establish
clear
human
milk
suppli
mixtur
potenti
far
complex
nutrit
substrat
currier
protein
number
nutrient
suppli
neonat
bound
protein
found
human
milk
bind
may
play
import
role
make
nutrient
bioavail
lactoferrin
ironbind
protein
properti
also
may
play
role
bacteriostat
action
appar
absorb
intact
infant
lactoferrin
may
import
improv
absorpt
iron
infant
human
mitk
compar
cow
milk
prepar
contain
littl
lactoferrin
also
may
bind
miner
includ
zinc
manganes
although
prefer
miner
form
appear
ferric
ion
number
protein
appear
import
carrier
vitamin
hormon
folatebind
vitamin
b
bind
vitamin
dbind
protein
identifi
human
milk
protein
appear
resist
proteolysi
especi
satur
appropri
vitamin
l
g
ad
serum
albumin
act
carrier
number
ligand
wherea
alactalbumin
act
carrier
calcium
final
protein
bind
thyroid
hormon
corticosteroid
report
present
human
although
serum
albumin
may
part
fulfil
function
enzym
activ
enzym
detect
human
enzym
appear
origin
blood
origin
secretori
epitheli
cell
mammari
gland
littl
known
role
enzym
lysozym
lipas
human
milk
enzym
found
human
milk
rang
atpas
antioxid
enzym
catalas
phosphatas
glycolyt
enzym
although
enzym
import
role
normal
bodi
metabol
clear
mani
either
function
milk
surviv
ingest
infant
function
neonat
lysozym
appear
part
antibacteri
function
human
milk
wherea
lipas
nutrientrel
role
modul
fat
metabol
neonat
two
lipas
identifi
human
milk
lipoprotein
lipas
bile
saltstimul
l
p
ae
lipoprotein
lipas
appear
involv
determin
pattern
lipid
found
human
milk
regul
uptak
milk
level
mammari
gland
human
milk
bile
saltstimul
lipas
acidst
protein
compens
low
activ
lipas
secret
digest
tract
earli
develp
thu
two
enzym
regul
amount
pattern
lipid
appear
milk
well
extrem
effici
absorpt
lipid
infant
human
milk
lipid
absorb
much
readili
lipid
commerci
milk
formula
despit
mani
adapt
made
improv
absorpt
illustr
effect
mechan
support
lipas
hormon
growth
factor
peptid
steroid
hormon
well
growth
factor
identifi
trace
amount
human
milk
although
enzym
clear
degre
function
neonat
suppli
discuss
previous
bind
protein
corticosteroid
thyroxin
identifi
milk
extrapol
observ
milk
compon
may
play
role
make
bioactiv
compound
readili
avail
infant
among
hormon
identifi
human
milk
insulin
oxytocin
calcitonin
prolactin
hormon
appear
absorb
infant
role
vivo
function
remain
breastf
infant
appear
differ
endocrin
respons
formulaf
infant
presum
reflect
intak
hormon
human
milk
advantag
disadvantag
infant
respons
howev
unknown
human
milk
also
contain
rich
mixtur
growth
factor
includ
epiderm
growth
factor
egf
nerv
growth
factor
addit
varieti
gastrointestin
peptid
identifi
human
milk
presum
suppli
variou
factor
infant
milk
compens
possibl
defici
infant
earli
develop
composit
human
milk
provid
complex
complet
nutrit
substrat
neonat
human
milk
suppli
individu
nutrient
also
enzym
involv
metabol
carrier
improv
absorpt
hormon
may
regul
metabol
rate
commerci
formula
yet
develop
point
provid
analog
complet
nutrit
system
fresh
human
milk
contain
wealth
compon
provid
specif
well
nonspecif
defens
infecti
agent
environment
macromolecul
tabl
compon
factor
includ
cell
b
lymphocyt
polymorphonuclear
neutrophil
pmn
ie
polymorphonuclear
leukocyt
macrophag
solubl
product
especi
immunoglobulin
secretori
immunoglobulin
siga
immunomodulatori
cytokin
cytokin
receptor
compon
complement
system
sever
carrier
protein
enzym
number
endocrin
hormon
hormonelik
substanc
addit
solubl
factor
activ
streptococci
staphylococci
tumor
virus
also
solubl
milk
factor
potenti
implic
host
defens
includ
bifidu
factor
promot
growth
bifidobacteria
egf
promot
growth
mucos
epithelium
matur
intestin
brush
border
development
characterist
siga
studi
extens
basi
avail
inform
clear
major
igaproduc
cell
observ
milk
origin
precursor
immunocompet
cell
gutassoci
lymphoid
tissu
galt
bronchusassoci
lymphoid
tissu
balt
exposur
iga
precursor
b
lymphocyt
galt
balt
microbi
dietari
antigen
mucos
lumen
import
prerequisit
initi
activ
prolifer
antigensensit
cell
eventu
transport
system
circul
mucos
surfac
includ
mammari
gland
plasma
cell
initi
synthesi
immunoglobulin
specif
antigen
previous
experienc
mucosa
respiratori
alimentari
r
propos
cell
observ
milk
also
may
deriv
galt
balt
manner
similar
igaproduc
cell
littl
inform
avail
regard
site
origin
cellular
solubl
immunolog
compon
normal
present
human
milk
specif
antibodi
cellular
immun
reactiv
mani
respiratori
enter
bacteri
viral
pathogen
ingest
food
protein
also
present
human
breast
milk
iga
antibodi
found
milk
possess
specif
immunoglobulin
observ
peripher
mucos
site
major
class
immunoglobulin
human
colostrum
milk
siga
isotypesnam
iga
igg
igm
igealso
present
iga
exist
dimer
two
iga
molecul
link
togeth
polypeptid
chain
jchain
associ
nonimmunoglobulin
protein
refer
secretori
compon
siga
protein
constitut
total
nitrogen
content
human
milk
iga
dimer
produc
plasma
cell
basal
surfac
mammari
epithelium
transport
special
columnar
epitheli
cell
acquir
secretori
compon
discharg
alveolar
sequenti
quantit
classspecif
immunoglobulin
human
colostrum
milk
demonstr
highest
level
siga
igm
present
first
day
lactat
fig
level
iga
time
greater
igm
time
greater
igg
time
greater
serum
lactat
progress
iga
declin
level
rang
mg
per
gram
protein
igm
level
declin
mgg
igg
level
show
signific
chang
earli
late
lactat
usual
maintain
rang
mgg
see
fig
although
dramat
rapid
declin
milk
iga
igm
occur
first
week
life
decreas
balanc
increas
volum
milk
produc
process
lactat
becom
establish
see
fig
infesi
agent
endem
pathogen
forth
intestin
respiratori
tract
see
tabl
antibodi
may
present
milk
absenc
specif
circul
iga
studi
pregnant
women
given
oral
feed
escherichia
coli
develop
iga
antibodi
human
milk
evid
absenc
detect
serum
antibodyspecif
respons
anoth
studi
investig
observ
similar
respons
anim
model
use
intrabronchi
immun
streptococcu
pneumonia
td
e
strongli
support
concept
bronchomammari
well
enteromammari
axi
immunolog
reactiv
breast
despit
eleg
studi
defin
mechan
iga
cell
traffick
galt
balt
mammari
gland
clear
actual
number
b
cell
iga
plasma
cell
mammari
gland
spars
time
colostrum
milk
may
contain
larg
amount
iga
much
g
colostrum
much
g
per
day
later
milk
shown
tabl
reason
underli
appar
dispar
content
immunoglobulinproduc
cell
concentr
immunoglobulin
known
may
relat
uniqu
hormon
environ
mammari
gland
hormon
consist
observ
human
milk
list
tabl
effect
pregnancyand
lactationrel
hormon
regul
immunolog
reactiv
present
rest
lactat
breast
studi
immunoglobulin
product
nonlact
human
breast
sever
interest
find
note
mononuclear
cell
present
nonlact
breast
nullipar
parou
women
although
igacontain
cell
predomin
synthesi
iga
appear
slightli
increas
parou
women
iga
found
mammari
tissu
prolif
stage
menstrual
cycl
nullipar
women
lute
phase
parou
women
number
igaproduc
cell
nonlact
breast
observ
increas
pariti
find
suggest
immunolog
makeup
nonlact
well
lactat
breast
may
significantli
influenc
hormon
milieu
anoth
studi
virgin
mice
given
exogen
administ
hormon
extend
exposur
estrogen
progesteron
prolactin
necessari
maxim
increment
igaproduc
plasma
cell
breast
similarli
castrat
male
expos
hormon
becam
moder
recept
mammari
gland
home
cell
specif
iga
synthesi
would
expect
testosteron
elimin
femal
breast
recept
cell
studi
suggest
exist
hormon
determin
home
mechan
mammari
gland
classspecif
immunoglobulinproduc
cell
recent
studi
propos
anoth
possibl
influenc
lactat
hormon
immunocompet
cell
limit
observ
combin
prolactin
estrogen
progesteron
concentr
observ
normal
begin
parturit
appear
amplifjmg
effect
synthesi
secret
iga
peripher
blood
lymphocyt
observ
rais
possibl
high
level
siga
observ
colostrum
milk
may
result
select
hormon
mediat
prolifer
antigensensit
iga
cell
peripher
blood
immunoglobulin
could
acquir
secretori
compon
passag
mammari
epithelium
eventu
appear
colostrum
milk
matur
siga
although
appear
siga
antibodi
milk
characterist
follow
antigen
exposur
galt
balt
precis
natur
iga
content
milk
appear
determin
varieti
factor
oper
mucos
lymphoid
tissu
includ
regulatori
cell
network
galt
possibl
natur
antigen
solubl
protein
versu
particul
microbi
rout
primari
versu
secondari
antigen
exposur
estim
breastf
infant
may
consist
receiv
amount
g
iga
day
approxim
yloo
amount
day
igm
estim
lactat
immunoglobulin
deliv
breastf
infant
differ
period
lactat
present
tabl
ingest
iga
elimin
fece
although
may
absorb
intestin
circul
within
first
hour
birth
approxim
ingest
milk
iga
surviv
passag
gut
excret
fece
breastf
infant
contain
function
antibodi
present
ingest
mi
studi
also
support
find
prolong
surviv
milk
iga
gastrointestin
tract
infant
fed
human
milk
demonstr
presenc
immunoglobulin
class
fece
fecal
iga
content
three
four
time
greater
igm
human
milk
feed
compar
studi
surviv
human
milk
iga
bovin
igg
neonat
intestin
tract
suggest
fecal
content
iga
may
time
greater
human
milk
feed
bovin
igg
feed
bovin
immun
globulin
direct
inform
role
milk
iga
antimicrobi
defens
avail
sever
studi
secretori
iga
interfer
bacteri
adher
cell
surfac
lo
colostrum
milk
inhibit
activ
e
coli
vibrio
choleru
enterotoxin
experiment
set
antitox
activ
human
milk
appear
correl
well
iga
content
igm
igg
content
precoat
v
choleru
specif
siga
protect
infant
mice
diseas
similar
result
obtain
use
specif
purifi
milk
siga
prevent
e
coliand
shigella
dysenteriueinduc
diseas
rabbit
less
definit
suggest
studi
conduct
human
milk
feed
rel
intestin
implant
oral
administ
live
polioviru
vaccin
studi
found
breastfeed
may
reduc
degre
seroconvers
polioviru
antibodi
vaccin
infant
antipolio
iga
present
human
milk
colostrum
investig
conclud
specif
iga
may
bind
polioviru
influenc
viral
replic
intestin
mucosa
extens
experi
oral
polio
immun
worldwid
howev
found
associ
breastfeed
live
vaccin
failur
studi
clearli
shown
magnitud
polioviru
replic
intestin
determin
presenc
level
preexist
siga
antibodi
high
level
intestin
iga
antibodi
littl
replic
vaccin
viru
observ
gut
lower
level
vari
degre
viral
replic
could
demnstrat
indirect
evid
obtain
clinic
perspect
suggest
protect
role
milk
varieti
mucos
infect
breastfeed
strongli
implic
support
gastrointestin
homeostasi
neonat
establish
normal
gut
flora
observ
shown
absenc
diarrheal
diseas
breastf
infant
even
face
contamin
fed
milk
e
coli
shigella
speci
prevent
therapeut
role
breastfeed
also
suggest
nurseri
outbreak
diseas
due
enteropathogen
strain
e
diarrhea
associ
rotaviru
breastfeed
play
inhibitori
role
appear
e
coli
agglutinin
found
fece
colon
infant
decreas
incid
neonat
sepsi
specif
associ
gramneg
bacilli
e
coli
serotyp
also
link
breastfeed
j
milk
iga
possibl
limit
ingest
foreign
antigen
neonat
bind
foreign
protein
specif
antibodi
prevent
absorpt
process
may
decreas
incid
atopicallerg
diseas
frequenc
ige
skin
testposit
result
describ
lower
among
breastf
infant
possibl
decreas
exposur
cow
milk
protein
presenc
matern
block
antibodi
indirect
epidemiolog
data
suggest
breastfeed
protect
certain
respiratori
bacteri
viral
infect
wherea
epidemiolog
studi
strongli
support
protect
role
breastfeed
possibl
studi
dissect
rel
contribut
siga
solubl
cellular
compon
present
colostrum
milk
aestirn
base
avail
data
total
immunoglobulin
daili
protein
synthesi
see
refer
immunoglobulin
g
immunoglobulin
normal
neonat
exhibit
characterist
pauciti
lack
iga
first
day
birth
time
presenc
igm
igg
milk
may
import
compens
immunolog
function
present
mucos
site
exampl
igg
igm
particip
complement
fixat
specif
bactericid
activ
function
associ
iga
studi
carri
oral
feed
immun
serum
globulin
mostli
igg
suggest
igg
may
surviv
gastrointestin
tract
lowbirthweight
infant
thu
immunoglobulin
isotyp
milk
also
may
abl
serv
effect
substitut
iga
neonat
igadefici
mother
prevent
infect
enter
respiratori
pathogen
releas
studi
milk
macrophag
found
effici
releas
superoxid
anion
vitro
stimul
phorbol
myrist
ae
e
milk
macrophag
capac
prime
appropri
stimul
greater
releas
superoxid
anion
shown
milk
macrophag
obtain
pretermdeliv
lactat
mother
significantli
higher
phagocyt
index
macrophag
term
milk
bactericid
activ
appear
similar
preand
fullterm
milk
macrophag
neutrophil
mdk
macrophag
appear
activ
demonstr
increas
express
ib
decreas
express
precis
function
macrophag
colostrum
milk
fulli
explor
cell
suggest
potenti
transport
vehicl
milk
macrophag
possess
phagocyt
activ
staphylococcu
aureu
e
coli
candida
albican
possibl
cytocid
activ
first
two
organ
milk
macrophag
particip
antibodydepend
cellmedi
cytotox
herp
simplex
viru
type
cell
infect
milk
macrophag
respiratori
syncyti
viru
result
product
proinflammatori
cytokin
illp
tumor
necrosi
factora
tnfcx
cell
also
involv
varieti
biosynthet
excretori
activ
includ
product
lactoferrin
lyozym
compon
crnplernent
properdin
factor
b
epitheli
growth
factor
lymphocytesuppress
factor
milk
macrophag
also
suggest
import
regul
cell
f
u
rc
n
human
colostrum
milk
contain
lymphocyt
monocytesmacrophag
neutrophil
epitheli
cell
earli
colostrum
contain
highest
concentr
cell
approxim
x
x
cell
per
ml
end
first
week
lactat
cell
concentr
order
cell
per
ml
total
cell
number
deliv
newborn
throughout
lactat
may
howev
remain
constant
adjust
made
increas
volum
milk
produc
two
major
cell
popul
human
milk
difficult
distinguish
common
stain
method
larg
number
intracytoplasm
inclus
neutrophil
macrophag
accur
estim
made
flow
cytometri
analysi
suggest
rel
percentag
neutrophil
macrophag
lymphocyt
earli
milk
sampl
approxim
repect
remain
cell
present
smaller
amount
especi
absenc
activ
suckl
engorg
local
breast
infect
colostr
cell
also
elicit
antibodyand
lectindepend
cellular
cytotox
respons
nk
well
antibodyand
lectindepend
respons
colostr
cell
howev
observ
significantli
lower
autolog
peripher
blood
cell
reduc
cellular
cytotox
colostr
cell
also
observ
virusinfect
target
certain
bacteria
fact
sever
specif
virusinfect
target
colostrum
mdk
cell
conspicu
lack
cellular
cytotox
compar
autolog
peripher
blood
cell
also
appar
exclus
cytolyt
cell
milk
specif
certain
human
leukocyt
antigen
hla
phenotyp
major
lymphocyt
colostrum
milk
matur
cell
helper
cytotox
suppressor
popul
present
human
milk
proport
cell
higher
found
human
blood
tabl
ratio
milk
significantli
lower
observ
peripher
blood
due
increas
cell
peripher
blood
women
postpartum
period
colostr
milk
lymphocyt
manifest
vitro
prolif
respons
stimul
number
mitogen
antigen
sever
studi
shown
select
lymphocyt
stimul
respons
colostr
milk
lymphocyt
variou
antigen
compar
peripher
blood
lymphocyt
antigen
rubella
viru
stimul
lymphocyt
secretori
site
milk
well
system
contrast
e
coli
antigen
whose
exposur
limit
mucos
site
produc
stimul
lymphoprolif
respons
milk
lymphocyt
find
support
concept
select
cell
popul
mammari
gland
addit
antigen
select
gener
hyporespons
mitogen
stimul
milk
lymphocyt
rel
peripher
blood
lymphocyt
r
v
e
decreas
reactiv
milk
lymphocyt
phytohemagglutinin
pha
may
partli
result
rel
defici
certain
popul
cell
milk
macrophaget
cell
interact
also
postul
respons
rel
hyporesponsi
although
known
whether
effect
result
decreas
helper
increas
suppressor
function
recent
studi
shown
milk
lymphocyt
exhibit
reduc
respons
allogen
cell
display
good
abil
stimul
treatment
milk
lymphocyt
monoclon
antibodi
cytotox
lymphocyt
antihla
class
antigenspecif
monoclon
antibodi
result
substanti
reduct
vitro
prolif
respons
bacteri
antigen
appear
gener
cell
prolif
respons
pha
tetanu
toxoid
breastf
infant
significantli
higher
bottlef
infant
possibl
secondari
presenc
matern
deriv
cell
growth
factor
lymphokin
present
human
virtual
cell
milk
bear
isoform
associ
immunolog
e
mr
addit
proport
cell
display
phenotyp
marker
activ
includ
hladr
much
greater
b
lo
consist
memori
phenotyp
cell
human
milk
produc
interferoni
ifni
furthermor
significantli
greater
number
cell
colostrum
express
ligand
compar
autolog
heterolog
blood
cognat
interact
cell
b
cell
necessari
step
antibodi
product
vivo
congenit
defici
newborn
function
memori
cell
recipi
human
infant
current
unknown
howev
mucou
membran
site
alimentari
respiratori
tract
recipi
infant
would
seem
potenti
entri
site
human
milk
leukocyt
consider
interest
small
number
memori
cell
detect
blood
infanc
thu
possibl
matern
memori
cell
milk
compens
development
delay
product
infant
regard
proport
lymphocyt
bear
cell
receptoryg
tcryg
approxim
two
time
greater
colostrum
b
lo
human
tcryg
cell
popul
organ
lymphoid
tissu
repres
half
intraepitheli
lymphocyt
thu
intestin
epithelia
may
select
affin
tcryg
cell
provid
favor
environ
matern
cell
milk
transfer
breastf
infant
evid
experiment
anim
studi
indic
milk
lymphocyt
enter
tissu
n
en
e
demonstr
human
addit
possibl
transfer
histocompat
antigen
cell
neonat
breastfeed
examin
determin
fate
skin
graft
suckl
rat
fed
allogen
mother
foster
feed
milk
may
result
increas
allogen
graft
surviv
also
develop
runt
syndrom
possibl
result
graftversushosttyp
reaction
breastf
anim
effect
transfer
may
relat
dosag
ingest
allogen
cell
increas
cell
number
transfer
may
prolong
skin
graft
surviv
may
also
increas
likelihood
graftversushost
reaction
note
suckl
rat
gut
higher
degre
permeabl
whole
protein
characterist
human
intestin
furthermor
clinic
experi
immunodefici
neonat
never
support
develop
graftversushost
reactionlik
diseas
breastf
human
infant
human
possibl
transfer
matern
cell
reactiv
tuberculin
protein
mother
neonat
throu
h
process
breastfeed
matern
cellular
product
solubl
mediat
cellular
reactiv
may
transfer
passiv
neonat
breastfeed
admittedli
howev
occurr
phenomena
human
studi
care
thu
must
emphas
present
evid
suggest
cellmedi
immunolog
risk
associ
breastfeed
human
lack
hand
still
unknown
whether
milk
cell
either
tcrav
tcryf
play
role
transfer
adopt
immunoprotect
recipi
infant
although
absolut
count
activ
nurs
mother
exhibit
consider
variabl
differ
sampl
highest
number
gener
observ
first
day
lactat
number
neutrophil
decreas
significantli
week
lactat
rare
neutrophil
observ
sampl
collect
day
post
partum
leukocyt
human
milk
appear
metabol
activ
inde
although
neutrophil
phagocyt
produc
toxic
oxygen
radic
respond
well
chemoattract
increas
adher
polar
direct
migrat
vitro
systemsim
diminish
respons
found
due
prior
activ
neutrophil
milk
display
phenotyp
pattern
typic
activ
neutrophil
express
lb
chain
subunit
increas
express
lselectin
epitheli
cell
basi
anatom
distribut
epitheli
cell
human
mammari
gland
classifi
two
main
type
myoepitheli
lumin
epitheli
cell
type
howev
appear
heterogen
histolog
physicochem
test
includ
secretori
cell
contain
abund
rough
endoplasm
reticulum
lipid
droplet
golgi
apparatu
secretori
cell
appear
produc
casein
micel
squamou
epitheli
cell
usual
seen
region
cutan
junction
nippl
especi
near
galactophor
ductal
lumin
cell
exist
cluster
mani
short
microvilli
tight
junction
remnant
desmosom
studi
use
monoclon
antibodi
shown
rodent
mani
differ
type
epitheli
cell
adult
mammari
gland
may
exist
cell
type
probabl
repres
variou
stage
differenti
mammari
gland
epithelium
includ
mammari
end
bud
distinct
cell
type
tip
main
compart
peripher
cell
type
alveoli
well
duct
mammari
gland
lumin
cell
type
myoepitheli
known
howev
whether
similar
epitheli
cell
differenti
occur
human
mammari
gland
human
milk
rel
epitheli
cell
observ
earli
phase
lactat
epitheli
cell
appear
week
seen
appreci
number
even
long
day
onset
lactat
possibl
except
synthesi
secretori
compon
casein
possibl
product
secretori
epitheli
cell
associ
stroma
mammari
gland
role
epitheli
cell
milk
remain
defin
possibl
function
role
cellular
element
inform
review
thu
far
provid
strong
evid
exist
number
dynam
cellular
reaction
mammari
gland
colostrum
milk
unfortun
specif
function
role
collect
individu
epitheli
cell
monocyt
neutrophil
lymphocyt
mammari
gland
milk
remain
defin
view
high
degre
select
differ
quantit
function
distribut
cellular
element
suggest
mammari
gland
like
mucos
surfac
may
function
somewhat
partit
cellular
element
peripher
blood
manner
similar
peripher
site
genit
tract
common
mucos
system
howev
known
whether
characterist
proport
macrophag
lymphocyt
cytotox
cell
epitheli
cell
design
specif
function
local
mammari
gland
lactat
mother
epithelium
lumen
intestin
respiratori
mucosa
breastfeed
infant
observ
transfer
delay
hypersensit
reaction
human
neonat
graftversushost
reactiv
rat
rais
possibl
milk
cell
may
function
import
vehicl
transfer
matern
immun
neonat
potenti
benefici
harm
role
cellmedi
transfer
mucos
rout
howev
need
investig
pauciti
nk
cytotox
cell
colostrum
may
role
breastfeed
neonat
especi
influenc
antigen
process
uptak
replic
microorgan
immun
respons
system
mucos
level
although
colostr
cell
await
elucid
function
mammari
gland
suckl
neonat
like
presenc
milk
repres
highli
select
phenomenon
mere
contamin
peripher
blood
cell
human
colostrum
milk
contain
compon
complement
system
activ
product
report
vitro
breast
milk
cell
cultur
interf
e
rn
migrat
inhibit
afetprotein
also
present
human
milk
although
role
yet
fulli
elucid
see
tabl
ironbind
protein
present
colostrum
milk
lactoferrin
bacteriostat
activ
vitro
e
coli
aureu
c
l
b
cn
evid
suggest
enhanc
bactericid
activ
lactoferrin
associ
iga
lysozym
bifidu
factor
collect
glycosamid
promot
growth
lactobacillu
bifidobacteri
speci
whose
growth
turn
inhibit
growth
enter
gramneg
aerob
bacilli
may
function
ancillari
inhibitor
gut
skin
pathogen
antistaphylococc
factor
appear
activ
experiment
staphylococc
infect
may
import
local
mammari
gland
prtection
particular
interest
demonstr
certain
oligosaccharid
prevent
attach
pneurnonia
human
epitheli
highmolecularweight
substanc
inhibit
virul
enterotoxin
enterobacteriacea
organ
see
tabl
nonimmunoglobulin
antivir
factor
demonstr
lipid
aqueou
phase
human
milk
factor
shown
activ
influenza
b
virus
herp
simplex
viru
semliki
forest
viru
japanes
b
enceph
viru
rubella
viru
rhinoviru
rotaviru
see
tabl
sever
recent
studi
gener
interest
potenti
role
nonantibodi
protein
bile
salt
lipas
whey
protein
trace
metal
present
human
milk
control
enter
infect
sever
speci
gramposit
gramneg
bacteria
frequent
kill
incub
human
milk
whey
commerci
infant
frrnula
mechan
respons
antibacteri
activ
known
synergist
interact
among
iga
lactoferrin
iron
suggest
play
role
e
f
e
ne
concentr
free
fatti
acid
possibl
monoglycerid
seem
increas
storag
milk
spontan
lipolysi
gener
lipoprotein
l
p
ae
antibodyindepend
antiparasit
effect
store
fresh
human
milk
giardia
lamblia
entamoeba
histolytica
attribut
free
fatti
acid
addit
studi
conduct
vitro
bile
saltstimul
lipas
major
lipas
human
milk
found
caus
hydrolysi
milk
triglycerid
remain
seen
whether
free
fatti
acid
induc
signific
vivo
protect
intestin
intestin
parasit
hand
bile
salt
may
stimul
growth
g
nonantibodi
protein
sever
carrier
protein
cellular
enzym
protein
present
milk
high
concentr
concentr
lysozym
rang
ml
earli
colostrum
ml
late
milk
suscept
organ
lysozym
depend
avail
peptidoglycan
substrat
certain
situat
peptidoglycan
may
block
lipoprotein
organ
rel
resist
l
yo
z
e
gener
featur
defens
agent
human
milk
although
biochem
divers
share
certain
featur
usual
common
mucos
site
adapt
resist
digest
gastrointestin
tract
recipi
infant
protect
noninflammatori
mechan
act
synergist
factor
produc
infant
compon
immun
system
human
milk
produc
throughout
lactat
gradual
wean
often
invers
relationship
product
factor
mammari
gland
product
infant
time
frame
lactat
postnat
develop
inde
lactat
proce
concentr
mani
factor
human
milk
declin
concomitantli
mucos
product
factor
rise
develop
infant
unclear
whether
invers
relationship
process
due
feedback
mechan
whether
process
independ
carbohydr
compon
human
milk
contain
sever
oligosaccharid
glycoconjug
includ
monosialogangliosid
receptor
analogu
heatlabil
toxin
produc
v
cholera
e
l
fucosecontain
oligosaccharid
inhibit
hemagglutinin
activ
classic
strain
v
holera
hcosyl
oligosaccharid
protect
heatstabl
enterotoxin
e
coli
mannosecontain
highmolecularweight
glycoprotein
block
bind
el
tor
strain
v
holera
glycoprotein
glycolipid
interfer
bind
colon
factor
cfnii
h
b
r
e
enterotoxigen
e
coli
inhibit
toxin
bind
associ
acid
glycolipid
contain
sialic
acid
gangliosid
although
quantiti
total
gangliosid
human
bovin
milk
similar
rel
frequenc
type
gangliosid
milk
two
speci
distinct
type
monosialyl
oligosaccharid
identifi
human
milk
new
type
still
monosialogangliosid
constitut
total
gangliosid
human
milk
percentag
much
lower
bovin
also
level
enterotoxin
receptor
gangliosid
g
time
greater
human
bovin
differ
may
clinic
import
gm
inhibit
enterotoxin
e
coli
v
chlera
also
interest
intact
human
milk
fat
globul
well
mucin
membran
structur
inhibit
bind
sfimbriat
e
coli
human
buccal
epitheli
cell
oligosaccharid
human
milk
also
interfer
attach
h
influenza
pnemonia
regard
nacetylglucosamin
glcnac
galdisaccharid
subunit
block
attach
pneumonia
respiratori
epithelium
moreov
recent
evid
indic
human
milk
interfer
bind
human
immunodefici
viru
hiv
envelop
antigen
molecul
cell
evid
anim
model
suggest
oligosaccharid
glycoconjug
human
milk
protect
relev
clinic
data
scarc
addit
direct
antimicrobi
effect
carbohydr
human
milk
nitrogencontain
oligosaccharid
human
milk
growth
promot
lactobacillu
var
pennsylvaniu
glycoprotein
glycpeptid
bifidu
growth
promot
activ
associ
casein
may
resid
oligosaccharid
moieti
complex
appear
factor
respons
great
extent
predomin
lactobacillu
speci
bacteri
flora
larg
intestin
breastf
infant
bacteria
produc
larg
amount
acet
acid
aid
suppress
multipl
enteropathogen
also
report
lactobacillu
speci
strain
gg
aid
recoveri
acut
rotaviru
infect
may
enhanc
format
circul
cell
produc
specif
antibodi
igg
iga
isotyp
well
serum
level
antibodi
substrata
human
milk
human
milk
suppli
defens
agent
fat
partial
digest
recipi
alimentari
tract
fatti
acid
monoglycerid
produc
milk
fat
bile
saltstimul
lipas
lipoprotein
lipas
human
milk
lingualgastr
lipas
recipi
pancreat
lipas
week
age
abl
disrupt
envelop
antivir
lipid
may
aid
prevent
coronaviru
infect
intestin
traci
also
may
defend
intestin
parasit
g
protein
princip
protein
human
milk
direct
antimicrobi
properti
includ
follow
alactalbumin
alactalbumin
major
compon
milk
protein
may
possess
import
function
immunolog
defens
protein
appear
larg
complex
sever
alactalbumin
molecul
induc
apoptosi
transform
embryon
lymphoid
cell
line
lower
number
aggreg
alactalbumin
molecul
bind
oleic
acid
cofactor
induc
cytolysi
sever
type
malign
cell
prepar
human
alactalbumin
made
lethal
tumor
cell
hamlet
highli
effect
induc
apoptosi
antitumor
cytolyt
activ
hamlet
also
observ
larg
number
human
tumor
lactofem
n
lactoferrin
domin
whey
protein
human
milk
singlechain
glycoprotein
two
globular
lobe
display
site
bind
ferric
lactoferrin
human
milk
form
apolactoferrin
ie
contain
ferric
iron
compet
siderophil
bacteria
fungi
ferric
thu
disrupt
prolifer
microbi
pathogen
epitheli
growthpromot
activ
lactoferrin
human
milk
also
may
aid
defens
recipi
infant
mean
concentr
lactoferrin
human
colostrum
mgml
volum
milk
product
increas
concentr
fall
mgml
month
l
n
resist
excret
lactoferrin
stool
hi
human
milkf
cow
milkf
infant
mean
intak
milk
lactoferrin
per
day
healthi
breastf
fullterm
infant
mgkg
month
lactat
mgkg
month
quantiti
lactoferrin
excret
stool
lowbirthweight
infant
fed
human
milk
approxim
time
stool
infant
fed
cow
milk
formula
estim
howev
may
high
presenc
immunoreact
fragment
lactoferrin
stool
human
milkf
infant
addit
signific
increment
urinari
excret
intact
fragment
lactoferrin
occur
result
human
mdk
fee
ding
recent
stabl
isotop
studi
suggest
increment
urinari
lactoferrin
fragment
princip
ingest
human
milk
latoferrin
lysozym
rel
high
concentr
lysozym
singlechain
protein
present
human
agent
lyse
suscept
bacteria
hydrolyz
linkag
nacetylmuram
acid
residu
cell
lysozym
rel
resist
digest
trypsin
denatur
due
acid
mean
concentr
lysozym
pgml
pgml
month
lactat
pgml
approxim
mean
daili
intak
milk
lysozym
healthi
fullterm
complet
breastf
infant
month
lactat
mgkg
month
studi
conduct
examin
fate
human
milk
lysozym
ingest
infant
amount
lysozym
excret
stool
lowbirthweight
infant
fed
human
milk
approxim
eight
time
found
stool
infant
fed
cow
milk
urinari
excret
protein
increas
result
human
milk
feed
fibronectin
fibronectin
highmolecularweight
protein
facilit
uptak
mani
type
particul
mononuclear
phagocyt
cell
present
human
milk
mean
concentr
colostrum
mgl
vivo
effect
fate
broadspectrum
opsonin
human
milk
known
complement
compon
compon
classic
altern
pathway
complement
present
human
milk
concentr
compon
except
except
although
direct
antiinflammatori
effect
human
milk
demonstr
vivo
number
clinic
observ
suggest
breastfeed
protect
recipi
infant
injuri
intestin
respiratori
r
n
u
cs
protect
may
due
part
rapid
elimin
neutral
microbi
pathogen
lumen
gastrointestin
tract
specif
broadspectrum
defens
agent
human
milk
featur
human
milk
suggest
sole
explan
phlogist
agent
system
give
rise
poorli
repres
human
contrast
human
milk
contain
host
antiinflammatori
includ
heterogen
group
growth
factor
cytoprotect
trophic
activ
mucos
epithelium
antioxid
antiproteas
cytokin
cytokin
receptor
antagonist
bioactiv
agent
inhibit
inflammatori
mediat
block
select
activ
leukocyt
like
antimicrobi
factor
factor
well
adapt
oper
hostil
environ
recipi
alimentari
tract
growth
factor
human
milk
includ
egf
transform
growth
factor
tgfcx
tgfp
lactof
e
r
k
mammari
glandderiv
growth
pl
n
e
host
includ
insulinlik
growth
factor
igf
vascular
endotheli
growth
factor
vegf
growth
hormonereleas
factor
ghf
hepatocyt
growth
factor
hgf
prolactin
leptin
may
affect
growth
matur
epitheli
barrier
limit
penetr
pathogen
microorgan
free
antigen
prevent
allerg
sensit
corticosteron
glucocorticoid
present
high
concentr
rat
milk
speed
gut
closur
neonat
although
macromolecular
absorpt
appear
mark
human
n
en
e
function
mucos
barrier
system
earli
infanc
import
host
defens
system
may
affect
factor
human
milk
regard
matur
intestin
tract
measur
mucos
mass
dna
protein
content
small
intestin
tract
appear
influenc
milk
particularli
earli
milk
antioxid
activ
colostrum
shown
associ
ascorb
compound
uric
acid
addit
two
antioxid
present
human
milk
c
oo
p
h
e
r
l
paroten
absorb
circul
recipi
gastrointestin
mucosa
serum
vitamin
e
concentr
rise
breastf
infant
mean
mgml
birth
approxim
mgml
fourth
day
life
pleiotrop
cytokin
potent
suppress
macrophag
cell
nk
cell
function
demonstr
high
concentr
sampl
human
milk
collect
first
hour
present
aqueou
phase
milk
also
lipid
layer
bioactiv
properti
confirm
find
human
milk
sampl
inhibit
blood
lymphocyt
prolifer
properti
greatli
reduc
treatment
antibodi
interest
mice
target
disrupt
gene
rais
convent
hous
condit
spontan
develop
gener
enterocol
becom
appar
age
week
time
wean
observ
suggest
human
milk
may
play
critic
role
homeostasi
immatur
intestin
barrier
regul
aberr
immun
respons
foreign
antigen
solubl
receptor
cytokin
receptor
antagonist
also
potent
antiinflammatori
agent
human
colostrum
matur
milk
shown
contain
biolog
activ
level
receptor
antagonist
solubl
tnfa
receptor
stnfari
stnfrii
vivo
relev
observ
also
confirm
chemic
induc
coliti
model
rat
anim
coliti
fed
human
milk
significantli
lower
neutrophil
inflamm
anim
fed
either
chow
infant
similar
protect
effect
seen
rat
coliti
fed
infant
formula
supplement
suggest
antiinflammatori
agent
present
milk
may
contribut
broad
protect
differ
injuri
provid
human
milk
feed
presenc
human
milk
plateletactiv
factor
acetylhydrolas
pafah
enzym
catalyz
degrad
inactiv
paf
inde
elev
serum
concentr
paf
found
rat
human
neonat
necrot
enterocol
nec
wherea
concentr
pafah
found
significantli
lower
control
unaffect
also
interest
serum
concentr
pafah
birth
adult
gradual
rise
enzym
activ
transfer
mucos
seros
fluid
intestin
neonat
rat
particularli
earliest
postnat
antiinflammatori
factor
present
human
milk
includ
igebind
factor
relat
antigen
fc
rii
loweraffin
receptor
suppress
vitro
synthesi
human
glycophosphoinositolcontain
molecul
protectin
inhibit
insert
complement
membran
attack
complex
mac
cell
target
vivo
fate
effect
antiinflammatori
factor
human
milk
still
poorli
understood
sever
seemingli
unrel
type
observ
suggest
breastfeed
modul
develop
immun
system
recipi
infant
prospect
retrospect
epidemiolog
studi
shown
breastf
infant
less
risk
develop
certain
chronic
immunolog
mediat
disord
later
childhood
includ
allerg
crohn
ulcer
insulindepend
diabet
e
l
l
ts
lymphoma
regard
cellmedi
immun
breastf
infant
given
bacil
calmettegukrin
bcg
vaccin
either
birth
later
show
significantli
higher
lymphocyt
transform
respons
purifi
protein
deriv
ppd
infant
never
breastf
moreov
matern
renal
allograft
surviv
better
person
breastf
nt
respect
vitro
allogen
respons
blood
lymphocyt
mother
stimul
cell
infant
respond
cell
measur
analysi
frequenc
cytotox
lymphocyt
ctl
precursor
direct
hla
alloantigen
ctl
allorepertoir
low
breastf
increas
level
certain
immun
factor
breastf
infant
could
explain
simpli
passiv
transfer
substanc
also
suggest
immunomodulatori
activ
human
milk
breastf
infant
produc
higher
blood
level
interferon
respons
respiratori
syncyti
viru
also
found
increment
blood
level
fibronectin
achiev
breastfeed
could
due
amount
protein
human
addit
found
human
milk
feed
led
rapid
develop
appear
siga
observ
suggest
abil
human
milk
modul
develop
infant
mucos
system
immun
system
may
associ
immunoregulatori
factor
present
colostrum
matur
milk
sever
differ
type
immunomodulatori
agent
identifi
human
among
numer
substanc
proven
potenti
abil
modul
infant
immun
respons
prlactin
atoopherol
lactferrin
antiidiotyp
ia
cytokin
evid
mani
factor
milk
primari
biolog
function
case
hormon
growth
factor
potenti
immun
regulatori
agent
overlap
antimicrobi
antiinflammatori
proper
tie
cytokin
human
milk
sever
cytokin
chemokin
growth
factor
mediat
effector
phase
natur
specif
immun
discov
human
milk
includ
illp
growthrel
peptidea
groa
monocyt
chemotact
granulocyt
colonystimul
factor
gcsf
macrophag
colonystimul
factor
mcsf
tgfp
tabl
human
milk
display
number
cytokinecharacterist
biolog
activ
includ
stimul
growth
differenti
immunoglobulin
product
b
cell
enhanc
thymocyt
inhibit
product
cell
suppress
ige
tnfa
first
two
cytokin
quantifi
human
milk
colostrum
tnfa
present
mainli
fraction
molecular
weight
kda
probabl
bound
solubl
receptor
milk
tnfa
secret
milk
macro
phage
mammari
first
demonstr
human
milk
specif
bioassay
studi
antibodi
eotaxina
gcsf
granulocyt
colonystimul
factor
gmcsf
granulocytemacrophag
colonystimul
factor
groa
growthrel
peptidea
il
interleukin
monocyt
chemotact
mcsf
monocyt
colonystimul
factor
rant
regul
upon
activ
normal
cell
express
secret
tgfb
transform
growth
factor
tnfa
tumor
necrosi
factora
inhibit
iga
product
colostrum
mononuclear
cell
suggest
may
involv
product
iga
mammari
gland
presenc
milk
also
demonstr
like
manner
local
highmolecularweight
fraction
human
milk
associ
receptor
studi
milk
although
express
receptor
mammari
secret
form
may
explain
high
molecular
weight
cytokin
human
milk
express
messeng
ribonucl
acid
mrna
protein
milk
cell
mammari
gland
epithelium
suggest
milk
mononuclear
cell
mammari
gland
like
major
sourc
presenc
ifni
human
milk
also
report
although
investig
found
signific
level
ifni
milk
sampl
obtain
mother
whose
infant
deliv
cesarean
section
signific
observ
clear
present
ifni
bioactiv
well
associ
specif
subset
milk
cell
also
remain
presenc
possibl
function
human
milk
discuss
section
antiinflammatori
agent
chemokin
novel
class
small
cytokin
discret
target
cell
select
abl
recruit
activ
differ
popul
lekocyt
two
major
subfamili
cxc
cc
chemokin
defin
splice
conserv
cystein
residu
separ
either
one
amino
acid
cxc
chemokin
adjac
amino
acid
cc
chemokin
groa
belong
cxc
famili
mainli
chemotact
factor
neutrophil
hand
cc
chemokin
includ
macrophag
inflammatori
proteinla
mipla
rant
regul
upon
activ
normal
cell
express
secret
chemotact
factor
monocyt
basophil
eosinophil
lymphocyt
presenc
cxc
cc
chemokin
describ
human
milk
see
tabl
concentr
first
determin
small
group
milk
sampl
basolo
investig
identifi
express
secret
mammari
epitheli
cell
although
milk
cell
also
appear
produc
h
e
k
n
e
anoth
member
cxc
chemokin
found
human
milk
groa
along
two
cc
chemokin
express
lesser
extent
rant
mrna
confirm
studi
milk
cell
recent
high
level
cc
chemokin
eotaxin
potent
specif
chemotact
factor
eosinophil
subtyp
helper
cell
also
demonstr
human
milk
colonystimul
factorshighli
specif
protein
factor
regul
cell
prolifer
differenti
process
hematopoiesiswer
discov
rel
recent
human
milk
although
colonystimul
activ
demonstr
milk
gcsf
mcsf
granulocytemacrophag
colonystimul
factor
gmcsf
specif
identifi
measur
human
milk
concentr
mcsf
particular
appear
serum
mcsf
evid
produc
epitheli
cell
duct
alveoli
mammari
gland
regulatori
activ
femal
sex
hormon
although
tempt
specul
cytokin
present
milk
may
abl
interact
mucos
tissu
respiratori
alimentari
tract
recipi
infant
function
express
specif
receptor
cytokin
epitheli
lymphoid
cell
airway
gastrointestin
mucosa
fulli
receptorindepend
mechan
cytokin
uptak
gastrointestin
mucosa
neonat
period
demonstr
date
sever
investig
examin
effect
prematur
earli
wean
galactorrhea
matern
malnutrit
process
lactat
immunolog
aspect
studi
focus
larg
evalu
total
content
siga
specif
antibodi
activ
describ
previous
mammari
secret
nonlact
breast
contain
siga
although
amount
appear
much
lower
lactat
mammari
secret
patient
galactorrhea
appear
contain
siga
concentr
similar
normal
postpartum
although
malnutrit
associ
reduc
secretori
antibodi
respons
extern
secret
matern
malnutrit
seem
affect
total
siga
concentr
antimicrobialspecif
antibodi
activ
mtk
nutrit
well
immunolog
composit
milk
mother
prematur
infant
appear
significantli
differ
milk
mother
infant
born
compar
studi
conduct
first
week
lactat
suggest
mean
concentr
lactoferrin
lysozym
higher
preterm
term
milk
secretori
iga
predomin
immunoglobulin
preterm
well
term
milk
although
siga
concentr
appear
significantli
higher
preterm
milk
collect
first
week
lactat
secretori
iga
antibodi
activ
certain
organ
e
coli
somat
antigen
preterm
milk
observ
somewhat
less
best
similar
found
term
milk
addit
number
lymphocyt
macrophag
milk
appear
lower
week
significantli
higher
week
milk
mother
preterm
born
week
gestat
age
infant
milk
fullterm
author
investig
propos
observ
chang
may
reflect
lower
volum
milk
produc
mother
deliv
preterm
infant
possibl
remain
chang
immunolog
profil
preterm
milk
may
consequ
inadequ
stimul
preterm
infant
alter
matern
hormon
milieu
factor
underli
prematur
deliveri
develop
mucos
integr
gut
appear
depend
matur
mucos
tissu
establish
normal
gut
flora
former
repres
anatom
enzymat
blockag
invas
microorgan
antigen
latter
inhibit
colon
pathogen
bacteria
although
permeabl
neonat
gut
immunoglobulin
rather
shortliv
incomplet
develop
unprotect
damag
neonat
gut
permeabl
host
protein
macromolecul
sever
week
longer
larg
milk
protein
peptid
bovin
serum
albumin
shown
enter
circul
produc
circul
antibodi
respons
inflam
ischem
gut
even
porou
antigen
pathogen
varieti
proven
presum
mechan
role
iga
normal
flora
propos
compens
temporari
inadequaci
evid
guttroph
substanc
human
still
preliminari
ampl
epidemiolog
evid
exist
posit
effect
breastfeed
establish
normal
gut
flora
compel
observ
rural
guatemala
gross
contamin
milk
potenti
pathogen
aerob
gramneg
bacilli
includ
e
coli
shigella
speci
absenc
diarrheal
ill
signific
number
organ
fece
infant
period
lactat
addit
divers
serotyp
aerob
gramneg
bacilli
present
oropharynx
gastrointestin
tract
neonat
may
serv
sourc
antigen
boost
presensit
mammari
gland
lead
modul
specif
bacteri
growth
precis
role
antibodi
block
adher
pathogen
gut
effect
factor
lactoperoxidas
lactoferrin
lysozym
bifidobacterium
bifidum
situat
undetermin
extens
epidemiolog
evid
support
prophylact
valu
breastfeed
prevent
amelior
diarrheal
diseas
summar
sever
ampl
experiment
anim
data
valu
specif
colostr
antibodi
prevent
diarrheal
ill
avail
studi
colostr
depriv
includ
colibacteriosi
associ
e
coli
swine
rotavir
gastroenter
cattl
swine
sheep
diarrheal
ill
associ
transmiss
gastroenter
swine
human
cholera
rare
infanc
especi
endem
area
preval
breastfeed
high
experi
outbreak
cholera
persian
gulf
lend
support
possibl
absenc
breastfeed
import
variabl
increas
risk
cholera
infanc
report
claim
nurseri
outbreak
diarrhea
associ
enteropathogen
strain
e
coli
interrupt
use
breast
milk
conflict
data
exist
regard
prevent
human
rotavir
infect
diseas
evalu
nurseri
outbreak
rotavir
diseas
suggest
incid
infect
ill
lower
breastf
infant
incid
symptom
formulaf
infant
also
low
studi
carri
japan
note
fivefold
decreas
incid
rotavir
infect
among
breastf
infant
younger
month
age
must
emphas
rotaviru
infect
neonat
asymptomat
regardless
breastor
bttlefeed
basi
care
clinic
observ
bishop
c
r
k
e
r
australia
first
question
posit
effect
breastfeed
rotaviru
infect
recent
casecontrol
studi
enter
viral
infect
breastf
infant
suggest
breastfeed
may
protect
infant
hospit
rather
infect
longitudin
followup
larg
cohort
infant
commun
outbreak
rotaviru
shown
attack
rate
rotaviru
infect
similar
breastf
bottlef
infant
frequenc
clinic
diseas
diarrhea
howev
appear
significantli
lower
breastf
infant
interest
protect
observ
patient
reflect
alter
microbi
flora
breastfeed
specif
immunolog
protect
rotaviru
thu
appear
breastfeed
provid
signific
protect
diarrheal
diseas
although
mechan
protect
remain
nec
complex
ill
stress
prematur
infant
often
associ
hypoxia
gut
mucos
ischemia
necrolysi
clinic
manifest
occas
associ
bacteremia
invas
gramneg
bacilli
particularli
klebsiella
pneumonia
intestin
submucosa
clinic
manifest
includ
abdomin
distent
gastric
retent
bloodi
diarrhea
classic
radiograph
find
includ
air
bowel
wall
pneumatosi
intestinali
air
portal
system
free
infradiaphragmat
air
signifi
perfor
treatment
involv
decompress
system
antibiot
often
u
r
g
e
r
number
studi
suggest
benefici
role
breast
milk
prevent
modifi
develop
nec
highrisk
human
infant
pediatr
center
claim
virtual
absenc
nec
breastf
infant
howev
mani
instanc
failur
milk
feed
prevent
human
nec
also
report
fact
outbreak
nec
relat
klebsiella
salmonella
speci
secondari
bank
human
milk
feed
document
asphyxi
neonat
rat
model
nec
entir
syndrom
could
prevent
feed
matern
milk
crucial
factor
milk
appear
cell
probabl
macro
phage
also
possibl
antibodi
nonspecif
factor
play
role
establish
gut
flora
prophylact
oral
administr
immunoglobulin
found
profound
influenc
outcom
nec
wellcontrol
penetr
gut
pathogen
antigen
increas
ischem
damag
noncellular
element
milk
may
aid
blockag
transit
role
enter
anaerob
organ
serious
consid
pathogenesi
nec
cytolyt
toxin
clostridium
dificil
clostridi
speci
demonstr
infant
nec
often
significantli
frequent
normal
clearli
nec
complex
diseas
entiti
whose
pathogenesi
caus
remain
defin
although
breastfeed
may
protect
number
factor
clearli
relat
mechan
mucos
injuri
pathogenesi
syndrom
incid
bacteremia
among
prematur
infant
fed
breast
milk
suggest
significantli
lower
among
receiv
formula
feed
shown
high
percentag
case
neonat
bacteremia
mening
caus
one
challeng
develop
human
milk
research
demonstr
breastf
infant
reduc
incid
diseas
autoor
dysregul
immun
long
termin
breatfeed
sinc
first
report
numer
publish
studi
address
effect
infant
feed
develop
atop
diseas
asthma
benefici
result
breastfeed
prophylaxi
atopi
observ
studi
other
howev
benefici
effect
report
infant
genet
determin
risk
atop
diseas
final
benefici
effect
even
increas
risk
suggest
breastf
infant
kramer
extens
metaanalysi
studi
publish
focus
infant
feed
atop
diseas
attempt
shed
light
c
n
r
oe
r
seven
studi
asthma
includ
analysi
claim
protect
effect
breastfeed
wherea
claim
protect
sever
seriou
methodolog
drawback
howev
note
analysi
number
studi
analyz
earli
infant
feed
histori
obtain
month
year
feed
period
ascertain
infant
feed
histori
obtain
interview
awar
diseas
outcom
insuffici
durat
exclus
breastfeed
document
confound
variabl
consid
inappropri
exposur
standard
nonblind
ascertain
diseas
outcom
found
common
violat
outcom
standard
kramer
analysi
also
found
failur
control
confound
variabl
common
violat
statist
analysi
standard
identifi
sever
studi
inde
effect
infant
feed
subsequ
asthma
may
confound
variabl
associ
infant
feed
uniqu
investig
condit
factor
seem
greatest
potenti
confound
effect
includ
famili
histori
atop
diseas
socioeconom
statu
parent
cigarett
smoke
studi
asthma
includ
metaanalysi
adequ
control
confound
factor
moreov
studi
demonstr
protect
effect
breastfeed
asthma
inadequ
statist
power
effect
infant
feed
sever
outcom
age
onset
diseas
virtual
ignor
although
extens
metaanalysi
may
suggest
uncertainti
prophylact
benefit
breastfeed
two
recent
studi
strongli
support
posit
effect
breastfeed
develop
atop
diseas
asthma
first
u
consist
prospect
longterm
evalu
infanc
age
year
preval
atopi
significantli
higher
infant
shortdur
less
month
breastfeed
increas
demonstr
differ
age
year
infant
intermediatedur
month
prolong
longer
month
breastfeed
differ
preval
atopi
persist
group
divid
accord
posit
neg
atop
hered
furthermor
atopi
manifest
differ
infant
feed
group
remain
constant
age
particular
respiratori
allergi
includ
asthma
increas
greatli
preval
age
year
preval
high
group
shortdur
breatfeed
second
studi
prospect
longitudin
studi
preval
risk
factor
acut
chronic
respiratori
ill
childhood
investig
examin
relationship
infant
feed
recurr
wheez
age
year
associ
lower
respiratori
tract
ill
associ
wheez
earli
life
children
never
breastf
significantli
higher
rate
recurr
wheez
year
age
increas
durat
breastfeed
beyond
month
associ
significantli
lower
rate
recurr
wheez
effect
breastfeed
appar
children
without
wheez
lower
respiratori
tract
ill
first
month
life
contrast
find
first
studi
howev
effect
breastfeed
signific
among
nonatop
children
exact
mechan
breastfeed
seem
confer
longlast
protect
allerg
sensit
poorli
understood
like
howev
multipl
synergist
mechan
may
respons
effect
includ
matur
recipi
gastrointestin
airway
mucosa
promot
growth
factor
present
human
inhibit
antigen
absorpt
milk
ia
reduc
incid
mucos
infect
consequ
sensit
bystand
chang
microbi
flora
intestin
breastf
direct
immunomodulatori
activ
human
milk
compon
recipi
number
earlier
recent
studi
greatli
contribut
understand
macromolecular
transport
across
immatur
gut
consequ
term
gener
circul
antibodi
immun
complex
process
block
predominantli
siga
glycocalyx
intestin
enzym
mucos
immunolog
event
basi
concept
immun
exclus
immun
exclus
absolut
howev
uptak
antigen
across
gut
may
enhanc
rather
block
interact
antibodi
mucos
surfac
begin
observ
igadefici
patient
becom
clear
absenc
iga
barrier
gut
associ
increas
incid
circul
antibodi
direct
mani
food
antigen
increas
occurr
atopicallerg
studi
note
complement
activ
serum
feed
bovin
milk
children
cow
milk
allergi
neonat
similar
respect
defici
increas
transintestin
uptak
food
antigen
consequ
circul
antibodi
format
prematur
infant
report
studi
suggest
earli
breastfeed
even
short
durat
associ
decreas
serum
antibodi
respons
cow
milk
prolong
breastfeed
may
partial
exclud
foreign
antigen
immun
exclus
may
also
mother
milk
infant
sole
food
prevent
must
howev
emphas
intact
bovin
milk
protein
food
antigen
antibodi
observ
sampl
colostrum
describ
previous
epidemiolog
evid
suggest
bacteri
viral
respiratori
infect
less
frequent
less
sever
among
breastf
infant
varieti
cultur
socioeconom
set
antibodi
immunolog
reactiv
direct
herp
simplex
viru
respiratori
syncyti
viru
infecti
ave
quantit
colostrum
milk
adopt
experi
suckl
ferret
shown
protect
young
respiratori
syncyti
viru
transfer
colostrum
contain
specif
antibodi
neonat
ferret
gut
howev
quit
permeabl
macromolecul
permit
passag
larg
quantiti
virusspecif
igg
absenc
either
document
antibodi
cellular
transfer
human
neonat
across
mucosa
mechan
protect
respiratori
syncyti
viru
respiratori
pathogen
remain
obscur
data
lack
human
regard
passiv
protect
mucos
surfac
eye
ear
genitourinari
tract
epidemiolog
evid
suggest
recurr
otiti
media
effus
strongli
associ
earli
bottlefeed
breastfeed
may
confer
protect
otiti
media
effus
first
year
foster
feedingacquir
antibodi
herp
simplex
viru
found
result
h
signific
protect
reinfect
challeng
experiment
anim
studi
number
benefit
associ
breastfeed
includ
natur
contracept
activ
protect
sudden
infant
death
high
cholesterol
level
ischem
heart
diseas
later
particular
recent
interest
associ
breastfeed
improv
intellectu
perform
older
children
sever
studi
demonstr
enhanc
cognit
outcom
breastf
children
although
controversi
exist
regard
mechan
improv
perform
may
health
benefit
mother
also
may
associ
breastfeed
reduc
incid
breast
cancer
note
women
sever
potenti
harm
effect
associ
breastfeed
provoc
data
suggest
nonautolog
human
milk
may
certain
condit
nutrit
inadequ
prematur
concentr
antirhesu
factor
antirh
antibodi
milk
appear
low
pose
threat
incompat
neonat
variabl
concentr
medicin
product
metabolit
excret
colostrum
milk
tabl
environment
contamin
dichlorodiphenyl
trichloroethan
ddt
polychlorin
biphenyl
pcb
mercuri
demonstr
high
concentr
human
failur
initi
lactat
properli
earli
breastfeed
may
present
risk
dehydr
infant
insuffici
fluid
may
ingest
inappropri
introduct
bottl
pacifi
also
may
interfer
proper
induct
lactat
later
lactat
introduct
bottl
may
induc
prematur
wean
result
reduct
milk
suppli
although
human
milk
optim
form
nutrit
healthi
term
infant
circumst
identifi
breastfeed
contraind
continu
breastfeed
conduct
caution
protect
infant
infant
inherit
metabol
diseas
may
best
nourish
treatment
altern
form
nutrit
particular
neonat
diagnos
galactosemia
need
galactos
remov
diet
word
need
switch
milk
contain
lactosefre
carbohydr
lactos
glucosegalactos
disaccharid
infant
diagnos
phenylketonuria
may
receiv
human
milk
support
requir
phenylalanin
often
may
better
manag
use
special
prepar
commerci
milk
manag
hyperbilirubinemia
associ
breastfeed
socal
breast
milk
jaundic
area
controversi
mechan
respons
form
jaundic
unknown
suggest
reflect
inhibitor
glucuronid
defici
relat
enzym
excess
lipid
breakdown
insuffici
milk
recent
recommend
suggest
laissezfair
approach
problem
increas
milk
volum
increas
number
feed
may
appropri
approach
breast
milk
jaundic
howev
sever
case
may
necessit
phototherapi
increas
intak
fluid
breastfeed
infant
appear
effect
mani
case
sever
instanc
specif
nutrient
defici
breastf
infant
describ
specif
relat
lack
vitamin
k
vitamin
vitamin
b
folk
acid
vitamin
c
carnitin
instanc
sever
case
report
appear
warn
defici
result
clinic
consequ
neonat
exampl
hemorrhag
diseas
report
breastf
infant
success
treat
vitamin
infant
receiv
vitamin
k
birth
mother
practic
unusu
dietari
habit
strict
vegetarian
may
reduc
level
vitamin
b
folic
acid
milk
defici
breastf
infant
mother
case
ricket
breastf
infant
report
particularli
winter
among
infant
expos
defici
carnitin
nutrient
respons
modul
fat
absorpt
also
report
result
clinic
symptom
breastf
infant
mother
ingest
unusu
e
h
variou
clinic
express
nutrient
defici
milk
concern
also
put
context
nutrient
defici
observ
formulaf
infant
clearli
million
infant
develop
countri
sever
risk
malnutrit
formulaf
econom
stress
suppli
suffici
formula
even
develop
countri
larg
number
nutrient
defici
associ
clinic
symptom
occur
result
accid
manufactur
notabl
accid
taught
us
effect
earli
vitamin
b
defici
folic
acid
defici
chlorid
defici
formula
feed
also
associ
increas
incid
diabet
thu
situat
aris
breastfeed
must
care
consid
appropri
feed
modal
infant
commerci
formula
also
repres
risk
howev
infant
best
serv
observ
pediatrician
mother
promptli
respond
clinic
sign
neonat
presenc
microbi
contamin
milk
seriou
concern
contamin
milk
implic
neonat
infect
uureu
group
b
hemolyt
streptococci
mycobacteria
possibl
salmonella
speci
tabl
mastiti
breast
abscess
associ
presenc
bacteri
pathogen
human
milk
inflamm
breast
often
resolv
even
continu
breastfeed
resolut
inflamm
may
relat
presenc
antisecretori
factor
af
factor
induc
milk
enterotoxinproduc
bacteria
appear
promot
recoveri
acut
bacteri
mastit
gener
feed
infant
breast
affect
abscess
recommend
infant
feed
affect
breast
may
resum
howev
mother
receiv
adequ
treatment
furthermor
breastfeed
may
continu
unaffect
breast
mother
activ
tuberculosi
refrain
breastfeed
least
week
longer
institut
appropri
treatment
consid
contagi
viral
contamin
matern
origin
milk
includ
rubella
viru
herp
simplex
viru
hepat
b
viru
hbv
cytomegaloviru
cmv
human
tlymphotrop
viru
type
htlvl
possibl
see
tabl
virus
although
transmiss
document
evidenc
seroconvers
seriou
ill
neonat
possibl
except
cmv
infectionrel
ill
secondari
breastfeed
reprt
occasion
report
possibl
neonat
herp
simplex
viru
infect
associ
presenc
viru
mother
milk
may
easili
caus
infanttomammari
gland
rather
mammari
glandtoinf
rout
incul
rnadepend
dna
polymeras
structur
protein
ctype
tumor
virus
possibl
relat
mous
mammari
tumor
masonpf
virus
identifi
human
breast
tissu
product
lactat
associ
breastfeed
femal
infant
develop
breast
cancer
hypothes
famili
strong
histori
carcinoma
breast
epidemiolog
evid
support
associ
lack
howev
breastfeed
may
fact
protect
factor
rel
matern
risk
neoplast
therefor
adher
reason
matern
hygien
absenc
intens
chemic
contamin
gener
proven
welldefin
contraind
natur
breastfeed
exist
current
recommend
regard
transmiss
infecti
viru
human
milk
implic
breastf
infant
summar
next
human
immunodefici
viru
infect
recent
seriou
concern
voic
regard
potenti
risk
transmiss
hiv
infect
mother
suckl
neonat
process
breastfeed
possibl
postnat
transmiss
viru
mother
child
consid
larg
number
infant
breastf
unit
state
part
world
infant
breastfeed
implic
one
major
risk
factor
acquisit
hiv
infect
sinc
small
signific
number
infant
hiv
infect
possibl
acquir
process
breastfeed
report
virtual
report
case
matern
seroconvers
hiv
antibodi
probabl
occur
deliveri
infant
mother
acquir
infect
heterosexu
transmiss
blood
transfus
mother
judg
intraven
drug
user
although
acquisit
hiv
infect
deliveri
rule
certainti
like
rout
transmiss
infant
presum
breastfeed
convinc
observ
base
sever
maternalinf
pair
matern
seroconvers
hiv
antibodi
occur
month
longer
number
studi
demonstr
hiv
find
includ
isol
hiv
milk
supernat
collect
symptomfre
women
cellular
fraction
matern
milk
recoveri
hiv
virion
histiocyt
cellfre
extract
milk
electron
microscopi
detect
viral
dna
polymeras
chain
reaction
pcr
assay
greater
sampl
hivseroposit
lactat
women
limit
epidemiolog
studi
carri
date
howev
fail
demonstr
magnitud
risk
hiv
infect
breastf
infant
cohort
stdi
differ
popul
suggest
increas
reduc
similar
transmiss
rate
breastfeed
nonbreastfeed
bottlefeed
infant
seroposit
mother
tabl
thu
appear
although
precis
epidemiolog
data
still
lack
major
breastf
infant
born
hivseroposit
mother
remain
uninfect
despit
presenc
htv
dna
milk
high
proport
mother
nevertheless
risk
acquisit
hiv
infect
breastfeed
must
ignor
basi
metaanalysi
avail
data
estim
addit
risk
hiv
infect
breastfeed
may
high
studi
suggest
breastfeed
contribut
increas
overal
vertic
transmiss
hiv
infect
despit
potenti
risk
hiv
infect
infant
hivinfect
breastfeed
mother
consider
cessat
breastfeed
must
balanc
benefici
effect
outlin
chapter
studi
breastf
hivinfect
children
progress
acquir
immunodefici
syndrom
aid
slower
rate
note
bottlef
hildren
current
estim
indic
overal
risk
acquir
hiv
infect
breastfeed
hivinfect
infant
may
infect
mean
breastfeed
among
breastf
month
longer
rate
infect
estim
approxim
among
breastf
month
less
rate
infect
approxim
howev
import
realiz
number
risk
factor
contribut
increas
transfer
hiv
breastfeed
associ
matern
factor
includ
younger
age
multipl
deliveri
high
viru
load
lower
number
lymphocyt
matern
mastiti
risk
factor
associ
matern
milk
includ
high
viral
load
milk
long
durat
breastfeed
especi
mix
formula
feed
breastfeed
low
level
antivir
factor
milk
low
ctl
siga
lactoferrin
lysozym
evid
oral
candidiasi
breastfeed
neonat
also
appear
risk
factor
develop
breastfeedingassoci
hiv
infect
current
recommend
american
academi
pediatr
state
popul
unit
state
risk
death
infecti
diseas
malnutrit
low
safe
effect
altern
sourc
feed
readili
avail
hivinfect
women
counsel
breastfe
infant
donat
milk
pregnant
women
unit
state
counsel
encourag
test
hiv
infect
data
avail
safeti
breastfeed
mother
receiv
highli
activ
antiretrovir
therapi
haart
geograph
area
infecti
diseas
malnutrit
import
caus
death
earli
life
feed
decis
may
complex
world
health
organ
state
mother
infect
hiv
replac
human
milk
decreas
risk
hiv
transmiss
may
prefer
breastfeed
provid
risk
associ
replac
feed
less
potenti
risk
hiv
transmiss
implement
suggest
mani
obstacl
polici
stress
need
continu
support
breastfeed
mother
hiv
neg
unknown
hiv
serostatu
improv
access
hiv
counsel
test
govern
effort
ensur
uninterrupt
access
nutrit
adequ
human
milk
substitut
cytomegaloviru
infect
cmv
infect
common
perinat
infect
viru
shed
milk
infect
mother
although
breastfeed
infect
mother
may
result
seroconvers
breastfeed
neonat
infect
often
associ
clinic
symptom
diseas
lowbirthweight
infant
born
less
g
howev
may
exhibit
evid
clinic
diseas
thrombocytopenia
neutropenia
hepatosplenomegali
seen
breastfeedinginfect
babi
decis
breastfe
prematur
babi
infect
mother
base
weigh
potenti
benefit
human
milk
versu
risk
cmv
transmiss
hepat
b
viru
infect
hepat
b
surfac
antigen
hbsag
detect
milk
hbvinfect
mother
nevertheless
breastfeed
increas
risk
hbv
infect
among
infant
infant
born
hbvposit
mother
receiv
hepat
b
immun
globulin
hbig
recommend
seri
hepat
b
vaccin
without
delay
institut
breastfeed
hepat
c
v
infect
rna
hepat
c
viru
hcv
antibodi
hcv
detect
milk
infect
mother
transmiss
mean
breastfeed
howev
document
antihcvposit
antihivneg
mother
accord
current
guidelin
hcv
infect
contraind
breastfeed
rubella
rubella
viru
recov
milk
natur
well
vaccineassoci
infect
associ
signific
diseas
infant
howev
although
transient
seroconvers
frequent
demonstr
contraind
breastfeed
exist
women
recent
immun
current
licens
rubella
vaccin
west
nile
v
infect
rna
west
nile
viru
detect
human
milk
seroconvers
breastfeed
infant
also
observ
although
west
nile
viru
transmit
milk
extent
transmiss
human
remain
determin
infant
children
infect
viru
date
asymptomat
minim
diseas
infect
due
human
tlymphotmp
virus
epidemiolog
studi
strongli
suggest
possibl
mothertoinf
transmiss
breastfeed
unit
state
current
recommend
women
breastfe
hand
statu
maternalinf
transmiss
process
breastfeed
well
establish
addit
inform
avail
breastfeed
recommend
seroposit
women
appar
human
colostrum
milk
richli
endow
wide
varieti
cellular
solubl
compon
particip
mani
nutrit
immunolog
antiinfect
process
specif
benefit
neonat
function
product
lactat
matern
breastfeed
best
character
date
nutrit
support
modul
andlor
compens
transient
mucos
immun
defici
infecti
dietari
macromolecul
autolog
infant
gener
quit
safe
mother
collect
milk
later
feed
directli
breastfe
neonat
nevertheless
increas
concern
regard
contamin
human
milk
infecti
agent
result
limit
use
either
milk
bank
wet
nurs
transfer
infecti
agent
matern
blood
milk
see
tabl
sever
nation
advisori
committe
recommend
patient
known
transmiss
infecti
viral
bacteri
diseas
breastfe
clinic
situat
withhold
breastfeed
appropri
high
metabolit
content
milk
includ
presenc
galactosemia
galactos
lactos
phenylketonuria
phenylalanin
amino
acid
disord
infant
shown
tabl
mani
drug
infecti
agent
environment
agent
transfer
infant
matern
milk
rather
stop
breastfeed
nurs
mother
avoid
use
drug
unless
absolut
essenti
mani
organohalid
fatsolubl
environment
product
ddt
pcb
may
present
higher
concentr
human
milk
although
much
known
risk
infant
gener
agre
unless
degre
exposur
mother
extrem
high
benefit
breastfeed
outweigh
possibl
risk
associ
environment
contamin
caffein
alcohol
nicotin
also
present
potenti
hazard
infant
see
tabl
advis
reduc
prefer
discontinu
intak
tobacco
caffeinecontain
product
alcohol
beverag
lactat
nurs
organ
endors
breastfeed
optim
mean
feed
healthi
term
infant
gener
percentag
mother
initi
breastfeed
develop
countri
higher
often
health
econom
consequ
bottlef
infant
countri
sever
howev
unit
state
one
point
earli
rate
breastfeed
initi
low
low
point
follow
increas
high
slow
declin
observ
modest
increas
observ
sinc
earli
pattern
breastfeed
initi
accompani
concomit
chang
mainten
breastfeed
month
chang
took
place
despit
goal
set
us
surgeon
gener
infant
breastfeed
first
week
life
goal
reestablish
year
within
unit
state
varieti
demograph
pattern
appear
associ
breastfeed
behavior
older
mother
mother
colleg
educ
higherincom
mother
like
breastfe
contrast
black
hispan
mother
mother
lower
socioeconom
statu
particip
women
infant
children
wic
program
us
depart
health
human
servic
mother
live
southern
region
unit
state
much
less
like
breastfe
low
rate
breastfeed
mother
enrol
wic
particular
concern
agenc
specif
polici
encourag
breastfeed
mani
state
howev
depend
formula
manufactur
rebat
fund
part
wic
program
creat
someth
conflict
interest
disturb
part
demograph
pattern
breastfeed
unit
state
infant
lowersocioeconomicstatu
mother
would
accru
greatest
health
econom
benefit
breastfeed
least
like
breastf
although
demograph
studi
indic
breastfeed
explain
behavior
differ
among
group
mother
one
complet
model
design
explain
breastfeed
behavior
includ
compon
address
matern
attitud
famili
societ
cultur
environment
individu
studi
shown
matern
decisionmak
process
close
relat
social
support
influenc
come
famili
member
surround
mother
husband
particular
appear
strong
posit
influenc
wherea
mother
mother
may
neg
influenc
breastfeed
decis
social
support
appear
differ
among
ethnic
group
matern
attitud
differ
may
provid
one
explan
differ
breastfeed
behavior
among
ethnic
clearli
human
milk
contain
wide
varieti
solubl
cellular
compon
divers
spectrum
biolog
function
major
milk
compon
identifi
date
exhibit
antimicrobi
antiinflammatori
proinflammatori
andor
immunoregulatori
function
cytotox
tumor
cell
abil
repair
tissu
damag
receptor
analogu
function
well
metabol
effect
rel
contribut
differ
milk
compon
biolog
effect
summar
tabl
bulk
antimicrobi
effect
associ
milk
immunoglobulin
especi
siga
isotyp
make
immunoglobulin
human
bodi
clinic
observ
demonstr
milk
antibodi
protect
larg
number
intestin
pathogen
campylobact
shigella
e
coli
v
cholera
giardia
rotaviru
respiratori
pathogen
respiratori
syncyti
viru
milk
antibodi
also
effect
neutral
toxin
varieti
human
virus
role
small
amount
igg
igm
milk
fulli
examin
recent
suggest
milk
igg
may
hydrolyz
nucleotid
gener
milk
iga
antibodi
induc
antimicrobi
protect
absenc
inflamm
characterist
complementbind
immunoglobulin
igg
igm
signific
number
pmn
macrophag
epitheli
cell
observ
milk
precis
function
milk
remain
determin
possibl
primari
task
defens
mammari
gland
lymphocyt
present
milk
transfer
immunolog
inform
may
offer
signific
cellmedi
immunolog
defens
suckl
neonat
breastf
infant
seem
becom
toler
mother
hla
may
import
implic
regard
immun
respons
allograft
reject
lactoferrin
major
milk
protein
also
may
play
import
role
antimicrobi
defens
kill
bacteria
fungi
virus
without
caus
inflamm
lactoferrin
also
found
block
mechan
result
express
proinflammatori
cytokin
tnfa
p
inhibit
nuclear
transcript
factor
nfkp
activ
recent
observ
suggest
alactalbumin
may
exist
human
milk
larg
complex
bind
oleic
acid
complex
refer
human
alactalbumin
made
lethal
tumor
cell
hamlet
induc
apoptosi
malign
cell
test
date
complex
remark
littl
effect
normal
cell
addit
recent
studi
suggest
milk
contain
larg
number
cytokin
chemokin
growth
factor
although
precis
role
milk
remain
determin
may
act
signal
recruit
proinflammatori
immunoregulatori
cell
mucos
site
tgfp
may
import
downregul
immun
respons
induct
toler
therebi
decreas
risk
allerg
diseas
may
promot
develop
ys
cell
popul
cryptopatch
small
aggreg
lymphocyt
intestin
crypt
mainten
thymu
also
shown
increas
level
b
tnfa
possibl
cytokin
increas
level
leptin
appetiteregul
hormon
present
signific
quantiti
mammari
epitheli
cell
milk
fat
globul
leptin
sever
immunolog
effect
includ
differenti
prolifer
hematopoiet
cell
regul
monocytemacrophag
function
also
influenc
cell
respons
enhanc
ifni
product
cell
product
cell
leptin
absorb
breastfeed
may
associ
prevent
obes
observ
breastf
infant
anoth
import
recent
observ
milk
relat
presenc
antisecretori
factor
af
observ
sampl
milk
possibl
induc
exposur
enterotoxinproduc
possess
signific
effect
intestin
fluid
secret
precis
function
af
remain
determin
preliminari
observ
howev
suggest
af
may
highli
effect
treatment
inflammatori
bowel
diseas
human
milk
found
possess
larg
quantiti
solubl
solubl
tolllik
receptor
import
element
innat
immun
promot
differenti
express
b
cell
function
antiinflammatori
effect
lactoferrin
intestin
epithelium
possess
possibl
milk
facilit
phagocytosi
organ
requir
express
ligand
bind
varieti
microorgan
may
play
import
role
downregul
inflammatori
respons
mucos
site
beyond
scope
chapter
explor
detail
reason
possibl
benefit
evolut
mammalian
life
form
nevertheless
passiv
transfer
divers
matern
biolog
experi
neonat
process
breastfeed
repres
essenti
compon
surviv
mechan
mammalian
neonat
million
year
matern
product
lactat
deliv
process
breastfeed
sole
sourc
nutrit
immun
neonat
period
earli
infanc
mammal
includ
human
infant
past
year
howev
human
societ
cultur
undergon
remark
chang
rapid
success
major
impact
basic
mechan
maternalneonat
interact
breastfeed
chang
includ
introduct
sanit
nonhuman
milk
formula
feed
neonat
nutrit
use
antimicrobi
agent
introduct
process
food
exposur
newer
environment
macromolecul
dietari
antigen
introduct
manmad
chang
neonat
environ
profound
impact
human
homeostat
mechan
time
allow
new
insight
role
breastfeed
develop
human
neonat
compar
analysi
natur
tradit
form
breastfeed
artifici
feed
modal
modern
time
demonstr
clearli
natur
breastfeed
associ
signific
reduct
infant
mortal
morbid
protect
acut
infecti
diseas
acut
phase
diseas
longterm
reexposur
possibl
protect
allerg
disord
autoimmun
diseas
acut
chronic
inflammatori
disord
obes
diabet
mellitu
metabol
disord
allograft
reject
develop
number
malign
condit
childhood
later
life
newer
evid
suggest
protect
role
breastfeed
modul
mani
respiratori
intestin
urinari
tract
infect
otiti
media
nec
neonat
inform
recent
review
hanson
eleg
despit
overwhelmingli
protect
role
attribut
natur
breastfeed
evolutionari
advantag
relat
develop
lactat
sever
infecti
agent
acquir
cours
evolut
abil
evad
immunolog
factor
milk
use
milk
vehicl
maternaltoinf
transmiss
potenti
acquisit
infect
due
hiv
htlv
cmv
possibl
pathogen
highlight
potenti
hazard
breastfeed
clinic
situat
thu
reason
conclud
develop
lactat
hallmark
mammalian
evolut
design
enhanc
surviv
neonat
speci
breastfeed
may
remark
spectrum
immedi
longterm
protect
function
